Bioventix PLC (LON:BVXP) Insider Bruce Hiscock Acquires 300 Shares

Bioventix PLC (LON:BVXP) insider Bruce Hiscock purchased 300 shares of the company’s stock in a transaction that occurred on Wednesday, October 30th. The shares were acquired at an average cost of GBX 3,330 ($43.19) per share, for a total transaction of £9,990 ($12,955.52).

Bioventix Price Performance

LON:BVXP opened at GBX 3,650 ($47.33) on Friday. The stock has a market cap of £190.53 million, a PE ratio of 2,248.47 and a beta of 0.35. Bioventix PLC has a fifty-two week low of GBX 2,977 ($38.61) and a fifty-two week high of GBX 5,100 ($66.14). The stock’s 50-day moving average is GBX 3,898.14 and its two-hundred day moving average is GBX 4,183.75.

Bioventix Increases Dividend

The business also recently disclosed a dividend, which will be paid on Thursday, November 21st. Investors of record on Thursday, November 7th will be given a dividend of GBX 87 ($1.13) per share. The ex-dividend date is Thursday, November 7th. This is an increase from Bioventix’s previous dividend of $68.00. This represents a yield of 2.4%. Bioventix’s payout ratio is presently 9,693.25%.

About Bioventix

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants.